# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-015357
Filing Date
2023-08-30
Accepted
2023-08-30 16:22:02
Documents
159
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | pahc-20230630x10k.htm iXBRL | 10-K | 4397534
2 | EX-10.18 | pahc-20230630xex10d18.htm | EX-10.18 | 33207
3 | EX-21.1 | pahc-20230630xex21d1.htm | EX-21.1 | 35309
4 | EX-23.1 | pahc-20230630xex23d1.htm | EX-23.1 | 1977
5 | EX-31.1 | pahc-20230630xex31d1.htm | EX-31.1 | 11661
6 | EX-31.2 | pahc-20230630xex31d2.htm | EX-31.2 | 11633
7 | EX-32.1 | pahc-20230630xex32d1.htm | EX-32.1 | 7244
8 | EX-32.2 | pahc-20230630xex32d2.htm | EX-32.2 | 7276
9 | GRAPHIC | pahc-20230630x10k009.jpg | GRAPHIC | 696
10 | GRAPHIC | pahc-20230630x10k010.jpg | GRAPHIC | 80480
| Complete submission text file | 0001558370-23-015357.txt |  | 17110263

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | EX-101.SCH | pahc-20230630.xsd | EX-101.SCH | 100009
12 | EX-101.CAL | pahc-20230630_cal.xml | EX-101.CAL | 132231
13 | EX-101.DEF | pahc-20230630_def.xml | EX-101.DEF | 366575
14 | EX-101.LAB | pahc-20230630_lab.xml | EX-101.LAB | 755492
15 | EX-101.PRE | pahc-20230630_pre.xml | EX-101.PRE | 764706
153 | EXTRACTED XBRL INSTANCE DOCUMENT | pahc-20230630x10k_htm.xml | XML | 3206864

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-36410 | Film No.: 231225513
SIC: 2834 Pharmaceutical Preparations